
HCA UK introduces bispecific antibody therapy for lung cancer at Birmingham hospital
HCA Healthcare UK has introduced bispecific antibody therapy for patients with extensive stage small cell lung cancer (ES-SCLC) at its Harborne Hospital in Birmingham, making it the first facility in the West Midlands to deliver the treatment. HCA was one …